There is no single Hamilton-wide checklist for safer opioid supply eligibility. A provider generally makes an individualized decision based on opioid use, current overdose or other supply-related risks, health history, treatment experience, goals, and the provider’s own program requirements. Health Canada’s safer supply information explains that eligibility depends on the service provider and is intended for people at risk of overdose when currently available care options have been ineffective or inappropriate.

Asking for an assessment is different from being approved, and discussing safer supply does not guarantee a particular medication. The most useful next step is to describe your circumstances honestly and ask what the Hamilton provider assesses, which documents are required, and what alternatives are available if safer supply is not appropriate.

Quick summary

• Eligibility is individualized. Living in Hamilton alone does not establish eligibility.
• Providers may review opioid use disorder, overdose risk, exposure to the unregulated supply, health history, and previous treatment experience.
• General intake requirements, such as age, identification, OHIP information, consent, and program policies, are not the same as safer-supply prescribing approval.
• An assessment does not guarantee Dilaudid, another specific medication, or approval.
• Prepare a clear history of opioid use, health conditions, medications, treatment experiences, and safety concerns.

What “eligibility” means for safer opioid supply in Hamilton

“Eligibility” can refer to several different decisions. A clinic may first determine whether you can begin its intake process. A clinician may then assess whether you have opioid use disorder and whether safer supply could reduce risks in your particular situation. The provider may also decide that another form of opioid addiction treatment or additional support is more appropriate.

These decisions should not be treated as one universal Hamilton standard. Safer supply is generally considered for people facing substantial harm from an unpredictable unregulated supply, particularly where conventional options have not reduced risk or are not acceptable. However, eligibility and service models vary by region and provider.

The key distinction is between requesting an assessment and meeting the clinical criteria for a prescription. A person may be able to discuss safer supply with a provider without being approved for it.

The main factors a provider may assess

A safer opioid supply assessment is intended to understand both the person’s needs and the risks associated with their current opioid supply. Providers may consider several factors together rather than relying on one answer or document.

Current overdose and supply-related risk

Expect questions about the substances being used, how often they are used, whether the strength or contents are unpredictable, and whether there have been overdoses or other serious harms. A provider may also ask about changes in supply, patterns of use, and circumstances that increase the likelihood of using alone or taking an unexpectedly potent product.

The purpose is not to test whether someone has the “right” story. It is to understand the actual level of risk and whether a prescribed alternative could be clinically appropriate. Safer opioid supply services are intended for people already at high risk from the unregulated supply, rather than people who are new to opioids.

Opioid use disorder and previous treatment experience

Providers may review whether the person meets the clinical definition of opioid use disorder, how opioid use affects daily life, and what treatment has already been tried. This may include methadone, buprenorphine-based treatment, other opioid agonist therapy, counselling, harm-reduction supports, or care from another provider.

Previous treatment may be relevant, but it should not be reduced to a rule that everyone must fail a specific medication first. Health Canada describes safer supply as intended for people for whom currently available care options have been ineffective or inappropriate, while the provider determines what that means in the individual case.

Health history, goals, consent, and follow-up

A clinical review may include physical and mental health conditions, other substances or medications, allergies, pregnancy-related considerations where relevant, and past reactions to treatment. The provider may also ask what you want help with, what risks concern you most, and whether you can consent to the proposed care.

Follow-up matters because safer supply is not simply a medication choice made once. The provider must consider how prescriptions will be monitored, how concerns will be addressed, and whether the proposed plan can be delivered safely. Discussing prescribed safer supply does not guarantee eligibility or a specific medication.

General Hamilton intake requirements versus safer-supply eligibility

Some requirements determine whether a person can begin an intake at a particular Hamilton clinic. They do not, by themselves, establish that safer opioid supply will be prescribed.

Question	What it may relate to	What to confirm
Are you 18 or older?	General clinic intake eligibility	Whether the provider accepts adults only and what options exist for younger people
Do you have valid photo identification and a valid OHIP number?	Registration and intake requirements	Which documents are accepted and what to do if information is missing
Is there evidence of opioid use disorder under DSM-5 criteria?	Clinical assessment for opioid treatment	How the provider completes the assessment
Can you provide consent and agree to program policies?	Participation in the clinic’s care process	What policies involve medication, visits, monitoring, and follow-up
Is safer supply clinically appropriate?	Prescribing decision	How overdose risk, health history, treatment history, and goals are weighed

The Hamilton clinic’s published intake information lists age, identification, OHIP, evidence of opioid use disorder, consent, and agreement to program policies as general intake considerations. The additional safer-supply decision requires a clinical review and should not be assumed from those intake conditions alone.

Why HART Hub eligibility does not answer every safer-supply question

Hamilton has services designed for people with complex needs, but eligibility for a broader health and housing hub is not automatically the criteria for safer-opioid-supply prescribing. Ontario’s HART Hub reference document describes a Hamilton service focused on adults who are homeless or at risk of homelessness, have complex service needs, and face a high risk of fatal overdose. It should not be read as a universal safer-supply checklist.

Similarly, the existence of a Hamilton program that provides prescribed alternatives and connections to medical or social services does not mean every person qualifies for every safer-supply service. The program, prescriber, available medication, and clinical circumstances all matter. Health Canada’s overview of opioid initiatives describes service examples without creating one province-wide approval rule.

Questions to ask before requesting an assessment

Ask the provider these questions before assuming that a program or medication is available to you:

• What are this program’s requirements for starting an assessment?
• Which parts of the assessment address overdose risk and exposure to the unregulated supply?
• What health information, medication list, identification, or OHIP information should I bring?
• Do I need previous experience with methadone, buprenorphine, or another treatment, and how is that experience considered?
• Which medications may be considered, and what determines the choice?
• What monitoring, appointments, or follow-up are expected?
• What happens if safer supply is not considered appropriate for me?
• Can I receive another opioid use disorder treatment, harm-reduction support, or referral while my options are reviewed?
• How will my information be kept confidential, and who can I contact after the assessment?

These questions help distinguish a genuine clinical assessment from an assumption that asking for safer supply guarantees approval. They also make it easier to compare the care pathway with other opioid addiction treatment options.

How to prepare for a Hamilton assessment

Write down your current opioid use as accurately as possible, including the type of product, frequency, route of use, changes in supply, and recent overdose or other safety concerns. Also list previous treatment, current prescriptions, health conditions, allergies, and mental health or social needs that could affect care.

Bring valid photo identification and OHIP information if the provider requests them. Prepare questions about medication options, monitoring, privacy, and alternatives. If a family member or support person will help you attend, ask whether that person can participate and what consent is needed.

Preparation can make the assessment clearer, but it cannot guarantee approval, a prescription, or a particular medication. If you are at immediate risk of overdose or another medical emergency, seek urgent emergency care rather than waiting for a routine assessment.

Frequently asked questions

Do I need to be 18 and have a valid OHIP number to begin a Hamilton clinic intake?

That depends on the clinic’s intake rules. The Hamilton requirements supplied for this article list being 18 or older and having valid photo identification with a valid OHIP number, along with evidence of opioid use disorder, consent, and agreement to program policies. Confirm current requirements directly, especially if you do not have one of these documents. Meeting intake requirements still does not guarantee safer-supply approval.

Do I have to try methadone or another opioid treatment before asking about safer supply?

Not necessarily as a universal rule. A provider may ask about previous treatment and whether available options were ineffective, inappropriate, or unacceptable in your circumstances. That history informs the assessment, but only the provider can explain how it applies to the program and your clinical situation.

Does an assessment guarantee Dilaudid or another specific medication?

No. An assessment does not guarantee Dilaudid, another medication, or approval for prescribed safer supply. The medication decision depends on clinical review, health and safety risks, treatment goals, follow-up considerations, and what the provider can appropriately offer.

What should I do if I am unsure whether I meet safer opioid supply criteria?

Ask a Hamilton provider for an assessment rather than trying to determine eligibility from a general checklist. Share your current opioid use, overdose or supply-related risks, health history, treatment experience, and goals. If safer supply is not appropriate, ask what other opioid use disorder treatment, harm-reduction, or health supports are available.

Making a safer, informed next step

Safer opioid supply eligibility in Hamilton is best understood as a provider-specific clinical decision, not a guaranteed benefit based on location or opioid use alone. The most important preparation is to understand the difference between general intake requirements and prescribing approval, describe current risks honestly, and ask how the provider evaluates treatment history, health, consent, and follow-up.

For an Ontario outpatient assessment pathway that includes Hamilton services, Road To Recovery provides information about its safer opioid supply program, Hamilton intake requirements, and available treatment options. Contact the clinic directly to confirm current eligibility requirements and discuss the next appropriate step.